[1]
“Scientific and technological prospection on the use of Cannabis sativa (Hemp) in neuropathic patients or with neuropsychiatric disorders”, RSD, vol. 12, no. 2, p. e5112236990, Jan. 2023, doi: 10.33448/rsd-v12i2.36990.